Centre Hospitalier Universitaire Vaudois (Chuv)

Centre Hospitalier Universitaire Vaudois (Chuv) is a non-profit hospital and research institution located in Lausanne, Switzerland, registered in the U.S. government's System for Award Management (SAM.gov) since 2009. As a corporate entity with tax-exempt status, Chuv specializes in advanced medical research, particularly focusing on neurodegenerative diseases, cancer research, and innovative medical technologies. The institution has established itself as a significant international research partner for U.S. federal agencies, demonstrating expertise in cutting-edge biomedical research with potential clinical applications.

Chuv has received multiple federal grant awards primarily from the Defense Health Agency and Department of the Army Medical Command under the Military Medical Research and Development program. The organization's research portfolio includes projects such as developing a clinical-grade spinal cord neuroprosthesis for Parkinson's disease, investigating T-cell senescence to optimize ovarian cancer immunotherapy, and examining mechanisms of spinal cord stimulation for motor deficit improvements. The institution has also participated in numerous sub-grant awards with prominent U.S. research institutions like the University of Pennsylvania, University of Melbourne, Seattle Children's Hospital, Emory University, and Stanford University. These collaborative projects span diverse research domains including neurodevelopmental psychiatric disorders, medulloblastoma brain tumor treatments, HIV integration pathways, advanced medical imaging techniques, and coronary fractional flow reserve determination. Chuv's research consistently demonstrates a sophisticated approach to medical innovation, focusing on translational research with potential significant impacts on healthcare for military service members, veterans, and the broader public.